What is the Impact Factor of Cancer Cytopathology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cancer Cytopathology is 2.90, ranking in quartile Q3 of Web of Science (SCIE).

Is Cancer Cytopathology indexed in Web of Science or Scopus?

Yes, Cancer Cytopathology is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.983 (Q2) and an H-index of 78.

Who publishes Cancer Cytopathology and what is the Article Processing Charge (APC)?

Cancer Cytopathology is published by Wiley-Blackwell. The estimated Article Processing Charge (APC) is approximately $3,395 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cancer Cytopathology?

The official ISO-4 abbreviation of Cancer Cytopathology is "CANCER CYTOPATHOL" with common acronym "cancercyto". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #5,033Hybrid

Cancer Cytopathology

Acronym:cancercyto

•

Abbreviation (ISO):CANCER CYTOPATHOL

•

Identifier (ISSN):1934-662X(Print)/1934-6638(Online)

•

Publisher:Wiley-Blackwell

Official Website Submission Portal Compare

Clarivate IF (2026)

2.9↓ -0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Cytopathology

WoS Q3

Annual Impact Factor Metric

Current (2026):2.9

Scopus SJR & RankScopus Q2

0.983

#5,033

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

78 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate15.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

68articles/year

40.56% Gold OA•88.76% Original Research

Aims & Scope

Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.

Topics Covered (Recognized by AI)

Medicine99.9%Biology77.4%Genetics70.7%Pathology69.3%Internal medicine67.7%Cytology45%Cancer44.7%Radiology39.3%Chemistry30.5%Biochemistry29.5%Biopsy25.6%Endocrinology23.2%Cytopathology21.9%Physics21%

Primary Research Areas

Medicine Pathology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank175/333

IndexSCIE

JCRSCIE2026

PATHOLOGY

Rank30/89

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank108/333

IndexSCIE

JCISCIE2026

PATHOLOGY

Rank32/89

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	175/333	Q3
PATHOLOGY	JCRSCIE	30/89	Q2
ONCOLOGY	JCISCIE	108/333	Q2
PATHOLOGY	JCISCIE	32/89	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.9

Articles / Year84

Total Citations14

2025

IF3.2

Articles / Year101

Total Citations157

2024

IF2.6

Articles / Year119

Total Citations404

2023

IF3.4

Articles / Year120

Total Citations678

2022

IF4.264

Articles / Year145

Total Citations1,146

Year	Impact Factor	Articles / Year	Total Citations
2026	2.9	84	14
2025	3.2	101	157
2024	2.6	119	404
2023	3.4	120	678
2022	4.264	145	1,146
2021	5.284	131	1,398
2020	3.703	183	3,122
2019	4.425	149	2,698
2018	3.866	147	2,713
2017	—	163	4,014
2016	—	149	3,216
2015	—	152	4,000

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,033Scopus Q2SCImago Profile

Scopus Coverage:2008-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q2

0.983

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.13

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,395 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations785

3-Year Documents321

Citable Documents223

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ2

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 15.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Cytopathology (acronym: cancercyto, abbr: CANCER CYTOPATHOL, ISSN: 1934-662X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell in United States. The periodical holds a Journal Impact Factor (JIF) of 2.90, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.983 (Q2), an H-index of 78.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 68 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,395 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.